The US contributes significantly to the growth of the defibrillator market in North America. The U.S. is expected to contribute significantly due to rise in adoption of innovative defibrillator technology. Hospitals and clinics in the U.S. are equipped with latest defibrillation devices and applications, which are essential to perform critical cardiac arrest. Cleveland Clinic, Mayo Clinic, New York-Presbyterian University Hospital of Columbia, and Cornell are some of the key hospitals contributing to the growth of defibrillator market.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/us-defibrillators-market
Further, there are organizations such as Oklahoma Health Care Authority (OHCA) and Indiana Health Care Association (IHCA) for public health in the US. Each year, over 350,000 emergency medical services-assessed out-of-hospital cardiac arrests occur in the US.CARES, a non-profit organization, designed to help emergency medical services (EMS) agencies, evaluates and improves their performance in cardiac arrest response, and monitors and reports data on patients who received EMS treatment (CPR and/or defibrillation). As a result, the total incidence reported by each database ranges from approximately 180,000 to 395,000 cases.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/us-defibrillators-market
According to Center for Disease Control & Prevention (CDC), the U.S. national healthcare expenditure was around $3 trillion in 2014. The U.S. has the highest healthcare spending across the globe. In the U.S., the per capita healthcare expenditure per person in 2014 was around $9,523. The North American market has the highest contribution from the US due to significant development in defibrillator market and presence of world’s finest hospitals. The U.S. has a considerable contribution in defibrillator market, however rise in medical tourism and high cost of implantable defibrillation may affect the growth of defibrillator market in the U.S.
Market Segmentation
US Defibrillators Market by Type
- Implantable Cardioverter Defibrillators
- External Cardioverter Defibrillators
US Defibrillators Market by End-Users
- Hospitals
- Ambulatory Services and Others
Company Profiles
- Abbott Laboratories, Inc.
- Biotronik SE & Co. KG
- Cintas Corp.
- Defibtech, LLC
- General Electric Co.
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic PLC
- Mindray Medical International Co. Ltd.
- Nihon Kohden Corp.
- Stryker Corp.
- ZOLL Medical Corp. (an Asahi Kasei Group company)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
